Octreotide acetate | CAS:83150-76-9

We serve Octreotide acetate CAS:83150-76-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Octreotide acetate

Chemical Name:Octreotide acetate
CAS.NO:83150-76-9
Synonyms:Octreotide acetate
Octreotide
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 1447.2±65.0 °C at 760 mmHg
Molecular Formula C49H66N10O10S2
Molecular Weight 1019.239
Flash Point 829.1±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.673
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Octreotide acetate is a longer acting synthetic octapeptide analog of naturally occurring somatostatin. It inhibits the secretion of gastro-entero-pancreatic peptide hormones and the release of growth hormone.



Contact us for information like Octreotide acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Octreotide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Octreotide acetate Use and application,Octreotide acetate technical grade,usp/ep/jp grade.


Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.4-(Trans-4-pentylcyclohexyl) phenyl boronic acid manufacturer Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.2-Fluoro-5-(trifluoromethyl)aniline supplier This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.Methyl coumalate vendor Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days.That impacts airlines’ business, making it less financially attractive for them to fly those routes to China.